当前位置: X-MOL 学术Med. Res. Rev. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Corrigendum: Molecular targeting therapies for neuroblastoma: Progress and challenges
Medicinal Research Reviews ( IF 13.3 ) Pub Date : 2021-07-11 , DOI: 10.1002/med.21843


[Article in Medicinal Research Reviews. https://doi.org/10.1002/med.21750]

Article first published online: 06 November 2020

The authors would like to add a conflict of interest disclosure. The Conflict of Interest Disclosures statement should read: Drs. Xian and McKeon have financial interests in Tract Pharmaceuticals, Inc. No other disclosures were reported.

The authors apologize for this oversight. This error does not change the scientific results of the article in any way.



中文翻译:

勘误:神经母细胞瘤的分子靶向治疗:进展和挑战

[医学研究评论中的文章。https://doi.org/10.1002/med.21750]

文章首次在线发表:2020 年 11 月 6 日

作者想添加利益冲突披露。利益冲突披露声明应为: Drs。Xian 和 McKeon 在 Tract Pharmaceuticals, Inc 拥有经济利益。没有其他披露报告。

作者为此疏忽道歉。此错误不会以任何方式改变文章的科学结果。

更新日期:2021-07-11
down
wechat
bug